Allergy medications - An Overview

If it is decided that the desired circumstances are fulfilled, future, Examine the dealing with standing / stock position of prescription drugs against several insurance pharmacies close to the handle from the medical institution / insurer, and acquire the outcomes. Also deliver to health-related institutions. Then again, if it is set that the desired situations will not be satisfied, the prescription suggestion issue derived based on the insured person's information introduced because of the clinical institution in just a selection that matches the specified conditions of your assessment payer as well as the insurance company Distribute an index of medicines to clinical institutions and persuade them to reselect.

Male MD collects and merchants a variety of knowledge when you finally use our Services. The specific kinds of information we purchase will rely on the Skilled products and services you utilize, but may perhaps contain the following: Individual Information and points: Person details indicates facts related to or accustomed to determine or Get keep of a specific male or woman.

This Site is utilizing a safety assistance to guard by itself from online assaults. The action you simply carried out triggered the security solution. There are various actions that can bring about this block such as submitting a specific term or phrase, a SQL command or malformed information.

最後に、一連の照会履歴を審査支払機関及び保険者に配信し、情報照会・判定の手順を終了する。

【解決手段】保険医療機関が処方する医薬品について、代替品情報、保険者の処方希望優先順位情報を入力・保持する手段、審査支払機関によるレセプト審査承認のための条件・基準を入力・保持する手段、医療機関から診療行為毎に、処方医薬品の保険適用可否に関する照会を受付け、被保険者の症状等の個人情報に基づき、照会内容が保険者・審査支払機関の指定条件に合致しているか否かを判定する手段、上記照会内容が指定条件に合致していない場合は、保険者が指定する医薬品の中から、症状等の被保険者の情報に基づき指定条件を満たす他の医薬品を検索し代替品として医療機関に通知、医療機関にて処方内容の再選択を促す手段を有するシステム。

システムの運用段階では、以下の処理をリアルタイムで実施する。すなわち、個々の診療行為に際して保健医療機関からの処方医薬品の保険適用の可否の問い合わせが通信回線を介して行われ、この問い合わせを前述の審査支払機関及び保険者の入力情報や指定条件に照らし合わせて、審査支払機関及び保険者が保険適用を却下しないか否かを判定し結果を医療機関に配信し、図６に示されるような入出力画面によって医療機関の端末に表示される。尚、判定の結果、問い合わせ内容が審査支払機関及び保険者の入力情報や指定条件に適合しない場合には、これらを満たす医薬品群を検索・同定し、医療機関に配信する。併せて、指定条件を満たした医薬品については、医療機関や被保険者の住所の近くに存在する保険薬局数軒での当該医薬品の取扱情報・在庫情報を保険薬局のデータベースにアクセスし確認を行う。また、保険薬局が、医療機関が発行した処方箋に記されている医薬品の保険適用につき照会を行う場合には、処方箋発行医療機関との照会履歴の有無、結果について配信する。

The healthcare prescription information inquiry / distribution system according to claim 1, whereby the health-related prescription is been given from the professional medical institution for each health care exercise, and insured information (clinical insurance plan related information, damage and disease) offered through the clinical establishment at time of inquiry.

At this time, an information process that replaces the development and application of the above mentioned-stated receipt having an electronic system from a conventional written approach has already been set into sensible use. However, in The us, Pharmacy Reward Administration (“PBM”) is a business that manages dispensing prices for policyholders.

And when you here receive an inquiry about health-related prescriptions from a healthcare institution for each person healthcare observe, insured person information (healthcare insurance linked information, information on sickness / indications, and so on.

Precedence date (The priority date is undoubtedly an assumption and is not a legal conclusion. Google has not done a lawful analysis and would make no representation as to your accuracy from the date stated.)

結果として、医療サービス受給の公平性を保ちつつ、代替品が存在する医薬品の中で、被保険者・保険者や審査支払機関が、効果・価格等の観点から望ましいと考える医薬品を選択する機会が十分に提供されていない。

Concurrently, for prescription drugs that satisfy the required conditions, obtain the insurance plan pharmacy databases and Check out the handling and stock information on the prescribed drugs at quite a few insurance plan pharmacies near the tackle from the professional medical institution or perhaps the insured. . Additionally, when an coverage pharmacy helps make an inquiry regarding the insurance policy software of the drugs described within a prescription issued by a professional medical institution, the presence or absence of an inquiry historical past While using the prescription issuing healthcare institution and The end result are dispersed.

 Consider therapy modification - data demonstrate that the required brokers may possibly communicate with each other inside a clinically-substantial way and patient-particular evaluation need to be performed to determine whether some great benefits of concomitant therapy outweigh the hazards. Specific actions has to be taken in order to realize the advantages and/or lower toxicity of concomitant use. Keep away from mix - knowledge demonstrate that the desired brokers could connect with each other in the clinically-substantial way and the danger generally outweighs any likely profit. Concurrent use of such brokers is generally considered contraindicated. Examination Interactions - Listing of assay interferences when applicable

従って、本発明の課題は、わが国の医療保険制度の中で、医療サービス受給の公平性を維持しつつ、被保険者・保険者もしくは審査支払機関が、代替品の中から最も強く処方を希望する医薬品を、医療機関・保険薬局が、他の代替品の中から優先的に採用する機会を提供することを可能にさせる、医療用医薬品処方情報照会・配信システムを提供することにある。